Xealth is a digital health platform that enables healthcare organizations to prescribe and monitor health tools, programs, and services.
Xealth's investors include Novartis, Cleveland Clinic, UPMC, LRVHealth, McKesson.
Xealth is headquartered in Seattle, United States.
Xealth is a digital health platform that enables healthcare organizations to prescribe and monitor health tools, programs, and services.
Xealth is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Xealth — Funding & Investors." VCBacked, March 25, 2025, https://www.vcbacked.co/company/xealth. Accessed August 14, 2026.
VCBacked. (2025). Xealth — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/xealth
{{cite web |title=Xealth — Funding & Investors |url=https://www.vcbacked.co/company/xealth |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated